Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-195-9 | CAS number: -
Endpoint summary
Administrative data
Description of key information
No evidence of adverse effects following single oral or dermal exposure
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- oral: unspecified
- Vehicle:
- other: none
- No. of animals per sex per dose:
- 5 male
5 female - Control animals:
- not specified
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities occurred
- Clinical signs:
- other: No signs of toxicity were observed during the 14-day observation period.
- Gross pathology:
- No anomalies were observed during macroscopic examination of the animals at autopsy, that were considered to have arisen as a result of treatment.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Not considered harmful.
- Executive summary:
Due to the lack of information provided by ECHA, it is difficult to assess this end point fully. It appears from information provided that the substance has low toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD0
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The study is considered as a reliable study.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD0
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is considered as reliable.
Additional information
Due to the lack of information provided by ECHA, it is difficult to assess this end point fully. It appears from information provided that the substance has low toxicity. The inhalation study has not been performed due to use being limited to chemical industry applications where suitable risk management measures can be implimented.
Justification for classification or non-classification
Based on data provided, the substance does not require classification for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
